Table 4 Predictors of 28-day mortality adjusted for patients with HFNC failure, univariate analysis
Variable | Survive, N = 117 | Death, N = 16 | P value |
|---|---|---|---|
Age, years old | 64 [55.5–72] | 68 [53.25–71] | 0.84 |
BMI, kg/m2 | 25.9 ± 5.0 | 27.7 ± 5.6 | 0.11 |
Smoking status, past or current (%) | 75 (64.1) | 11 (68.8) | 0.79 |
COPD | 16 (13.7) | 2 (12.5) | 1.00 |
Malignancy | 8 (6.8) | 2 (12.5) | 0.34 |
Cardiovascular disease | 19 (16.2) | 3 (18.8) | 0.73 |
Cerebrovascular disease | 10 (8.6) | 2 (12.5) | 0.64 |
Diabetes mellitus | 35 (29.9) | 8 (50.0) | 0.15 |
Hypertension | 53 (45.3) | 12 (75.0) | 0.03 |
LDH level, U/L | 519 [436–655] | 613.5 [464.75–793.5] | 0.20 |
CRP level, g/dL | 9.35 [5.25–12.50] | 5.75 [3.11–12.57] | 0.18 |
ROX index | 6.20 ± 2.51 | 4.89 ± 2.04 | 0.04 |